TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
FTRE

Fortrea Holdings Inc.

Healthcare · Biotechnology

20.00$ +0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow FTRE
Line item 2020 2021 2022 2023 2024 2025
7.8% 5.6% 2.9% 5.9% 9.7% 4.2%
4.6% 5.4% 3.3% 3.4% 3.6% 2.9%
0.9% 0.9% 0.9% 1.5% 2.2% 2.7%
0.3% -4.2% -8.7% 0.9% 13.5% 4.2%
0.9% 0.9% 1.9% 1.4% 0.9% 0.9%
-6.2% -0.9% -1.9% -1.1% 9.3% 0.5%
0.0% 0.0% 56.9% -17.9% -2.8%
-1.3% -4.2% -0.2% -5.0% -18.5% -2.8%
0.3% 0.5% 0.6% -0.1% 0.4% 2.1%
6.9% 4.7% 1.0% 4.5% 8.8% 3.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?